Home » AMDL ANNOUNCES SECOND CLOSING OF PRIVATE OFFERING
AMDL ANNOUNCES SECOND CLOSING OF PRIVATE OFFERING
AMDL, Inc. (Amex: ADL), developer and marketer of tests for the early detection of cancer and other serious diseases, announced today that it has conducted the second closing of a combined Regulation D/Regulation S private offering of shares and warrants. The offering generated total gross proceeds of $1,007,000, exclusive of placement agent fees of $130,910.
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May